3 Healthcare Stocks Showing Why the Sector Still Has Momentum
The healthcare sector has performed fairly well so far in 2026 due to several factors: GLP-1 medications continue to drive new business and interest, while groundbreaking AI applications help enhance and accelerate the drug discovery process. On top of that, potential mergers and acquisitions activity, as big pharmaceutical companies face a major patent cliff, could provide opportunities for new firms to stand out.
Hinge Health Inc. (HNGE) Up 13.7% Since Last Earnings Report: Can It Continue?
Hinge Health Inc. (HNGE) reported earnings 30 days ago. What's next for the stock?
One Platform, Every Ailment: Hinge Health's Gamble
Many people know that seemingly unrelated symptoms can be connected. But in most cases, treating individual symptoms means a separate doctor visit, sometimes to different specialists, before the full picture emerges.
HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue?
Hinge Health's nearly 90% YTD surge is backed by 53% revenue growth, wider margins and expansion into migraine and GI care, but execution risks remain.
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.
Is Hinge Health Stock a Buy as Growth Accelerates and Risks Rise?
HNGE's rapid revenue growth, widening margins and higher 2026 outlook strengthen its case, but expansion raises execution risks.
Hinge Health's Cylinder Deal Opens a $135B GI Care Growth Opportunity
HNGE's $105 million Cylinder deal opens a $135 billion GI care market, adding nearly 100 clients and about 2 million lives.
HNGE Rallies 64.6% in 3 Months as Growth and Margins Gain Momentum
Hinge Health 64.6% three-month rally is backed by surging revenues, wider margins and a raised 2026 outlook, but execution expectations are rising.
Is the Options Market Predicting a Spike in Hinge Health Stock?
Investors need to pay close attention to HNGE stock based on the movements in the options market lately.
Boost Your Portfolio Returns With These 4 Top-Ranked Liquid Stocks
IVZ, HUBS, HNGE and PGNY make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.
HNGE Q2 Earnings Meet Estimates, Sales Top, '26 View Raised, Stock Up
Hinge Health's Q2 revenues jump 53% as stronger member yield, margin gains and raised 2026 guidance reinforce business momentum.
Hinge Health Q2 Earnings Call Highlights
Hinge Health NYSE: HNGE reported second-quarter 2026 revenue of $213 million, up 53% from a year earlier and above the company's prior guidance range of $200 million to $202 million. The digital healthcare company also raised its full-year revenue and operating-income outlook, citing durable improvements in member engagement, or yield, alongside continued margin expansion.
